Status:

COMPLETED

Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva

Lead Sponsor:

Queen Mary University of London

Collaborating Sponsors:

GlaxoSmithKline

Conditions:

Covid19

Coronavirus

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a single-blind, parallel-group, randomized pilot study designed to evaluate and compare the efficacy of 3 different mouthwashes containing 0.2% Chlorhexidine digluconate, 1.5% Hydroxide peroxi...

Eligibility Criteria

Inclusion

  • All of the following criteria must be fulfilled for inclusion:
  • Patients must have willingness to read and sign a copy of Informed Consent Form.
  • Males and females, ≥ 18 years old.
  • COVID-19 positive patients confirmed via any diagnostic test and/or presented with COVID-19 clinical symptoms at point of consent.
  • Exclusion criteria for patients
  • Patients presenting with any of the following will not be included in the trial:
  • Known pre-existing chronic mucosal lesions e.g. lichen planus or other oropharyngeal lesions, reported by patient or recorded in the existing patient' medical notes;
  • Patients currently intubated or not capable of mouth rinse or spit;
  • History of head and neck radiotherapy or chemotherapy;
  • Self-reported xerostomia;
  • Known allergy or hypersensitivity to chlorhexidine digluconate or one of the mouthwashes constituents;
  • Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or may interfere with the interpretation of trial results and, in the judgement of the investigator, would make the subject inappropriate for entry into this trial;
  • Inability to comply with study protocol.

Exclusion

    Key Trial Info

    Start Date :

    May 19 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 25 2021

    Estimated Enrollment :

    54 Patients enrolled

    Trial Details

    Trial ID

    NCT04723446

    Start Date

    May 19 2021

    End Date

    October 25 2021

    Last Update

    September 14 2023

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Newham Hospital

    London, United Kingdom

    2

    Royal London Hospital

    London, United Kingdom